JP2017536335A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536335A5
JP2017536335A5 JP2017518100A JP2017518100A JP2017536335A5 JP 2017536335 A5 JP2017536335 A5 JP 2017536335A5 JP 2017518100 A JP2017518100 A JP 2017518100A JP 2017518100 A JP2017518100 A JP 2017518100A JP 2017536335 A5 JP2017536335 A5 JP 2017536335A5
Authority
JP
Japan
Prior art keywords
hal
independently
substituted
sor
cor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518100A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536335A (ja
JP6835711B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/002008 external-priority patent/WO2016050359A1/en
Publication of JP2017536335A publication Critical patent/JP2017536335A/ja
Publication of JP2017536335A5 publication Critical patent/JP2017536335A5/ja
Application granted granted Critical
Publication of JP6835711B2 publication Critical patent/JP6835711B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518100A 2014-10-01 2015-10-01 ボロン酸誘導体 Expired - Fee Related JP6835711B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14003392.9 2014-10-01
EP14003392 2014-10-01
PCT/EP2015/002008 WO2016050359A1 (en) 2014-10-01 2015-10-01 Boronic acid derivatives

Publications (3)

Publication Number Publication Date
JP2017536335A JP2017536335A (ja) 2017-12-07
JP2017536335A5 true JP2017536335A5 (https=) 2019-10-17
JP6835711B2 JP6835711B2 (ja) 2021-02-24

Family

ID=51690789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518100A Expired - Fee Related JP6835711B2 (ja) 2014-10-01 2015-10-01 ボロン酸誘導体

Country Status (14)

Country Link
US (1) US10294246B2 (https=)
EP (1) EP3201207B1 (https=)
JP (1) JP6835711B2 (https=)
KR (1) KR102450583B1 (https=)
CN (1) CN107001390B (https=)
AU (1) AU2015327346B2 (https=)
BR (1) BR112017006420A2 (https=)
CA (1) CA2963205A1 (https=)
ES (1) ES2873000T3 (https=)
IL (1) IL251301B (https=)
MX (1) MX370336B (https=)
RU (1) RU2017115188A (https=)
SG (1) SG11201702623TA (https=)
WO (1) WO2016050359A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017115191A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты
JP6662865B2 (ja) 2014-10-01 2020-03-11 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ボロン酸誘導体
RU2017115193A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты
PL3672977T3 (pl) 2017-08-24 2022-09-26 Merck Patent Gmbh Pochodne kwasu boronowego
SG11202100727VA (en) 2018-07-26 2021-02-25 Merck Patent Gmbh Boronic acid derivatives
CN113135944A (zh) * 2020-01-19 2021-07-20 首药控股(北京)有限公司 硼酸衍生物
CN113135943A (zh) * 2020-01-19 2021-07-20 首药控股(北京)有限公司 硼酸衍生物
US20250340577A1 (en) * 2021-03-02 2025-11-06 Case Western Reserve University Beta-lactomase inhibitors and uses thereof
JP2024518834A (ja) * 2021-05-19 2024-05-07 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 雑草防除方法
WO2023006863A1 (en) 2021-07-29 2023-02-02 Merck Patent Gmbh Novel crystalline forms of [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7- oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid, adducts thereof, and processes to obtain
CN118119630A (zh) * 2021-10-14 2024-05-31 首药控股(北京)股份有限公司 硼酸衍生物
WO2023232830A1 (en) 2022-06-02 2023-12-07 Merck Patent Gmbh Boronic acid adducts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111175A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
WO2001002424A2 (en) 1999-07-07 2001-01-11 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
US7271186B1 (en) * 2002-12-09 2007-09-18 Northwestern University Nanomolar β-lactamase inhibitors
CA2705393A1 (en) * 2007-11-13 2009-05-22 Protez Pharmaceuticals, Inc. Beta-lactamase inhibitors
AR075090A1 (es) * 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
SG11201403254QA (en) * 2011-12-22 2014-07-30 Ares Trading Sa Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
RU2017115191A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты
JP6662865B2 (ja) 2014-10-01 2020-03-11 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ボロン酸誘導体
RU2017115193A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты

Similar Documents

Publication Publication Date Title
JP2017536335A5 (https=)
JP2018502048A5 (https=)
PH12016501813A1 (en) 1,3-benzodioxole derivative
ES2649995T3 (es) Benzamidas
AR119454A2 (es) COMPUESTOS ÚTILES COMO MODULADORES DE RORg, SALES FARMACÉUTICAMENTE ACEPTABLES DE LOS MISMOS, COMPOSICIONES FARMACÉUTICAS Y DICHOS COMPUESTOS PARA USO COMO MEDICAMENTO
AR106605A1 (es) Oxadiazoles sustituidos para combatir hongos fitopatógenos
PE20190258A1 (es) Antagonistas del receptor de la apelina (apj) mejorados y usos de los mismos
EA201892710A1 (ru) Карбамоилоксиметилтриазолциклогексильные кислоты в качестве антагонистов lpa
AR109788A1 (es) Compuestos de benzo[b]tiofeno como agonistas de sting
EA201692249A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
EA201692266A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
UY36275A (es) Compuestos aminopirimidinilo
AR106763A1 (es) Oxadiazoles sustituidos para combatir hongos fitopatógenos
MX379155B (es) Compuestos que inhiben la proteína mcl-1.
MX380928B (es) Inhibidores de kras g12c.
PE20180232A1 (es) Derivados de indol mono o disustituidos como inhibidores de la replicacion viral del dengue
AR099111A1 (es) Derivados de azepano y su uso para tratar infecciones de hepatitis b
EA201791304A1 (ru) Производные изохинолина для лечения вич
CR20160525A (es) Pirazolopiridinas y pirazolopirimidinas
AR104963A1 (es) Derivados de 2-(pirazolopiridin-3-il)pirimidina como inhibidores de jak
MX382122B (es) Oxiesteroles y metodos de uso de los mismos.
AR102171A1 (es) Compuestos sustituidos de aminopurina, sus composiciones y su uso en el tratamiento o prevención de melanoma
EA201692265A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
AR106138A1 (es) Compuestos y métodos para inhibir jak
EA201691670A1 (ru) Тетразолонзамещенные дигидропиридиноновые ингибиторы mgat2